Degradation of HER2 receptor through hypericin-mediated photodynamic therapy

Photochemistry and Photobiology

Volumn 86, Issue 1, 2010, Pages 200-205

  Kovaľ, Ján ^a   Mikeš, Jaromír ^a   Jendželovský, Rastislav ^a   Kello, Martin ^a   Solár, Peter ^a   Fedoročko, Peter ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BENZOTHIAZOLYL)THIOMETHYL 4 HYDROXY 3 METHOXYBENZYLIDENECYANOACETAMIDE; BENZOTHIAZOLE DERIVATIVE; DRUG DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HER2 PROTEIN, HUMAN; HYPERICIN; PERYLENE; TYRPHOSTIN;

APOPTOSIS; ARTICLE; BREAST TUMOR; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; METABOLISM; METHODOLOGY; PATHOLOGY; PHOTOCHEMOTHERAPY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; BENZOTHIAZOLES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; PERYLENE; PHOTOCHEMOTHERAPY; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; TYRPHOSTINS;

EID: 73649148706     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2009.00639.x     Document Type: Article

References (26)

1. Jemal, A., R. Siegel, E. Ward, T. Murray, J. Xu M. J. Thun (2007) Cancer statistics. CA Cancer J. Clin. 57, 43 66.
2. Slamon, D. J., W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Stuart, J. Udove, A. Ullrich M. F Press (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707 712.
3. Nielsen, D. L., M. Andersson C. Kamby (2009) HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors. Cancer Treat. Rev. 35, 121 136.
4. Knuefermann, C., Y. Lu, B. Liu, W. Jin, K. Liang, L. Wu, M. Schmidt, G. B. Mills, J. Mendelsohn Z. Fan (2003) HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells. Oncogene 22, 3205 3212.
5. Lerdrup, M., A. M. Hommelgaard, M. Grandal B. van Deurs (2006) Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way. J. Cell Sci. 119, 85 95.
6. Sidera, K., M. Gaitanou, D. Stellas, R. Matsas E. Patsavoudi (2008) A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2. J. Biol. Chem. 283, 2031 2041.
7. Tokunaga, E., Y. Kimura, E. Oki, N. Ueda, M. Futatsugi, K. Mashino, M. Yamamoto, M. Ikebe, Y. Kakeji, H. Baba Y. Maehara (2006) Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients. Int. J. Cancer 118, 284 289.
8. Allison, R., T. Mang, G. Hewson, W. Snider D. Dougherty (2001) Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality. Cancer 91, 1 8.
9. Cuenca, R. E., R. R. Allison, C. Sibata G. H. Downie (2004) Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann. Surg. Oncol. 11, 322 327. (Pubitemid 40486774)
10. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan Q. Peng (1998) Photodynamic therapy. J. Natl. Cancer Inst. 90, 889 905. (Pubitemid 28304157)
11. Cavarga, I., P. Brezani, M. Cekanova-Figurova, P. Solar, P. Fedorocko P. Miskovsky (2001) Photodynamic therapy of murine fibrosarcoma with topical and systemic administration of hypericin. Phytomedicine 8, 325 330.
12. Kleban, J., B. Szilardiova, J. Mikes, V. Horvath, V. Sackova, P. Brezani, J. Hofmanova, A. Kozubik P. Fedorocko (2006) Pre-treatment of HT-29 cells with 5-LOX inhibitor (MK-886) induces changes in cell cycle and increases apoptosis after photodynamic therapy with hypericin. J. Photochem. Photobiol. B 84, 79 88.
13. Blank, M., M. Mandel, Y. Keisari, D. Meruelo G. Lavie (2003) Enhanced ubiquitinylation of heat shock protein 90 as a potential mechanism for mitotic cell death in cancer cells induced with hypericin. Cancer Res. 63, 8241 8247.
14. Hwang, M. S., Y. N. Yum, J. H. Joo, S. Kim, K. K. Lee, S. W. Gee, H. I. Kang O. H. Kim (2001) Inhibition of c-erbB-2 expression an activity in human ovarian carcinoma cells by hypericin. Anticancer Res. 21, 2649 2655.
15. She, Q. B., S. Chandarlapaty, Q. Ye, J. Lobo, K. M. Haskell, K. R. Leander, D. DeFeo-Jones, H. E. Huber N. Rosen (2008) Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling. PLoS ONE 3, e3065. doi :.
16. Vivanco, I. C. L. Sawyers (2002) The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489 501.
17. Chen, T. C., S. Su, D. Fry L. Liebes (2003) Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma. Cancer 97, 2363 2373.
18. Kumar, R., M. Mandal, A. Lipton, H. Harvey C. B. Thompson (1996) Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells. Clin. Cancer Res. 2, 1215 1219. (Pubitemid 26238454)
19. Henson, E. S., X. Hu S. B. Gibson (2006) Herceptin sensitizes ErbB2-overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 expression. Clin. Cancer Res. 12, 845 853.
20. Kleban, J., J. Mikes, V. Horvath, V. Sackova, J. Hofmanova, A. Kozubik P. Fedorocko (2008) Mechanisms involved in the cell cycle and apoptosis of HT-29 cells pre-treated with MK-886 prior to photodynamic therapy with hypericin. J. Photochem. Photobiol. B 93, 108 118.
21. Pick, E., Y. Kluger, J. M. Giltnane, C. Moeder, R. L. Camp, D. L. Rimm H. M. Kluger (2007) High HSP90 expression is associated with decreased survival in breast cancer. Cancer Res. 67, 2932 2937.
22. Way, T. D., M. C. Kao J. K. Lin (2004) Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 279, 4479 4489.
23. Sureau, F., P. Miskovsky, L. Chinsky P. Y. Turpin (1996) Hypericin-induced cell photosensitization involves an intracellular pH decrease. J. Am. Chem. Soc. 118, 9484 9487.
24. Sackova, V., P. Fedorocko, B. Szilardiova, J. Mikes J. Kleban (2006) Hypericin-induced photocytotoxicity is connected with G2/M arrest in HT-29 and S-phase arrest in U937 cells. Photochem. Photobiol. 82, 1285 1291.
25. Tsai, C. M., A. Levitzki, L. H. Wu, K. T. Chang, C. C. Cheng, A. Gazit R. P. Perng (1996) Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells. Cancer Res. 56, 1068 1074.
26. Argiris, A., C. X. Wang, S. G. Whalen M. P. DiGiovanna (2004) Synergistic interactions between tamoxifen and trastuzumab (herceptin). Clin. Cancer Res. 10, 1409 1420.